Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Stewart

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|August 6, 1994
Apolipoprotein E and familial non-insulin-dependent diabetes mellitusR W Taylor, M W Stewart, P J Avery, et al.
Diabetes Care|February 1, 1995
Insulin sensitivity and mitochondrial gene mutationM Walker, R W Taylor, M W Stewart, et al.
Diabetes Care|July 1, 1995
Features of syndrome X in first-degree relatives of NIDDM patientsM W Stewart, D B Humphriss, T S Berrish, et al.
Thrombosis and Haemostasis|October 18, 1993
Detection of antiphospholipid antibodies by flow cytometry: rapid detection of antibody isotype and phospholipid specificityM W Stewart, W S Etches, A S Russell, et al.
Diabetes, Obesity & Metabolism|August 27, 2014
Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metforminJ Reusch, M W Stewart, C M Perkins, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 1, 1996
Human insulin receptor substrate-1: variant sequences in familial non-insulin-dependent diabetes mellitusM Armstrong, F Haldane, R W Taylor, et al.
Diabetes, Obesity & Metabolism|February 4, 2009
Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjectsM A Bush, J E Matthews, E H De Boever, et al.
Diabetes Care|November 1, 1995
Insulin and proinsulin secretion in subjects with abnormal glucose tolerance and a mitochondrial tRNA(Leu(UUR)) mutationM Walker, R W Taylor, M W Stewart, et al.
Diabetologia|February 12, 1998
Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM familiesD B Humphriss, M W Stewart, T S Berrish, et al.
Health Care Financing Review|March 3, 1997
National health expenditures, 1995K R Levit, H C Lazenby, B R Braden, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|August 6, 1994
Apolipoprotein E and familial non-insulin-dependent diabetes mellitusR W Taylor, M W Stewart, P J Avery, et al.
Diabetes Care|February 1, 1995
Insulin sensitivity and mitochondrial gene mutationM Walker, R W Taylor, M W Stewart, et al.
Diabetes Care|July 1, 1995
Features of syndrome X in first-degree relatives of NIDDM patientsM W Stewart, D B Humphriss, T S Berrish, et al.
Thrombosis and Haemostasis|October 18, 1993
Detection of antiphospholipid antibodies by flow cytometry: rapid detection of antibody isotype and phospholipid specificityM W Stewart, W S Etches, A S Russell, et al.
Diabetes, Obesity & Metabolism|August 27, 2014
Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metforminJ Reusch, M W Stewart, C M Perkins, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 1, 1996
Human insulin receptor substrate-1: variant sequences in familial non-insulin-dependent diabetes mellitusM Armstrong, F Haldane, R W Taylor, et al.
Diabetes, Obesity & Metabolism|February 4, 2009
Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjectsM A Bush, J E Matthews, E H De Boever, et al.
Diabetes Care|November 1, 1995
Insulin and proinsulin secretion in subjects with abnormal glucose tolerance and a mitochondrial tRNA(Leu(UUR)) mutationM Walker, R W Taylor, M W Stewart, et al.
Diabetologia|February 12, 1998
Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM familiesD B Humphriss, M W Stewart, T S Berrish, et al.
Health Care Financing Review|March 3, 1997
National health expenditures, 1995K R Levit, H C Lazenby, B R Braden, et al.
Pageof 8